Caxton Associates (New York)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,890
| Closed | -$1.92M | – | 602 |
|
|
2024
Q3 | $1.92M | Sell |
16,890
-6,251
| -27% | -$710K | 0.07% | 129 |
|
|
2024
Q2 | $2.86M | Buy |
23,141
+1,701
| +8% | +$211K | 0.1% | 108 |
|
|
2024
Q1 | $2.83M | Buy |
+21,440
| New | +$2.83M | 0.16% | 84 |
|
|
2023
Q3 | – | Sell |
-13,061
| Closed | -$1.51M | – | 539 |
|
|
2023
Q2 | $1.51M | Buy |
13,061
+9,630
| +281% | +$1.11M | 0.22% | 99 |
|
|
2023
Q1 | $365K | Buy |
+3,431
| New | +$365K | 0.06% | 316 |
|
|
2022
Q3 | – | Sell |
-15,089
| Closed | -$1.38M | – | 584 |
|
|
2022
Q2 | $1.38M | Buy |
15,089
+12,468
| +476% | +$1.14M | 0.13% | 58 |
|
|
2022
Q1 | $215K | Buy |
+2,621
| New | +$215K | 0.02% | 406 |
|
|
2021
Q2 | – | Sell |
-4,192
| Closed | -$308K | – | 529 |
|
|
2021
Q1 | $308K | Buy |
+4,192
| New | +$308K | 0.03% | 249 |
|
|
2020
Q3 | – | Sell |
-2,855
| Closed | -$211K | – | 430 |
|
|
2020
Q2 | $211K | Buy |
+2,855
| New | +$211K | 0.02% | 346 |
|
|
2019
Q2 | – | Sell |
-2,837
| Closed | -$225K | – | 471 |
|
|
2019
Q1 | $225K | Buy |
+2,837
| New | +$225K | 0.03% | 308 |
|
|
2018
Q2 | – | Sell |
-23,094
| Closed | -$1.2M | – | 403 |
|
|
2018
Q1 | $1.2M | Buy |
23,094
+2,862
| +14% | +$149K | 0.06% | 123 |
|
|
2017
Q4 | $1.09M | Buy |
+20,232
| New | +$1.09M | 0.05% | 152 |
|
|
2017
Q3 | – | Sell |
-9,432
| Closed | -$577K | – | 523 |
|
|
2017
Q2 | $577K | Buy |
9,432
+1,153
| +14% | +$70.5K | 0.02% | 224 |
|
|
2017
Q1 | $502K | Buy |
+8,279
| New | +$502K | ﹤0.01% | 191 |
|
|
2013
Q3 | – | Sell |
-5,240
| Closed | -$232K | – | 189 |
|
|
2013
Q2 | $232K | Buy |
+5,240
| New | +$232K | 0.01% | 120 |
|